A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer
Clinical trial NCT05033132 · WITHDRAWN
Trial details
- NCT number
- NCT05033132
- Sponsor
- Agenus Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2024-12-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.